{
  "ticker": "LLY",
  "target_date": "2025-05-05",
  "actual_date": "2025-05-05",
  "collected_at": "2025-12-08T11:43:23.329713",
  "price": {
    "open": 812.35,
    "high": 824.92,
    "low": 807.41,
    "close": 816.7835083007812,
    "volume": 2889600,
    "change_1d_pct": -0.26,
    "change_7d_pct": -4.45,
    "change_30d_pct": -1.92
  },
  "technicals": {
    "rsi_14": 58.74,
    "sma_20": 798.59,
    "sma_50": 826.47,
    "macd": 9.471,
    "macd_signal": 6.56,
    "macd_histogram": 2.912,
    "bb_upper": 919.74,
    "bb_lower": 677.44,
    "price_vs_sma20_pct": 2.28,
    "price_vs_sma50_pct": -1.17,
    "volume_ratio": 0.63
  },
  "fundamentals": {
    "market_cap": 889751273472,
    "pe_ratio": 48.629105,
    "forward_pe": 43.80053,
    "price_to_book": 37.368977,
    "price_to_sales": 14.973987,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.74,
    "pct_from_52w_low": 59.11
  },
  "macro": {
    "spy": {
      "price": 560.3,
      "change_1d_pct": -0.57,
      "change_7d_pct": 2.34
    },
    "vix": {
      "level": 23.64,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.34
    },
    "dollar_index": {
      "level": 99.83
    },
    "gold": {
      "price": 3311.3
    },
    "regime": "SIDEWAYS"
  },
  "news": [
    {
      "headline": "Lilly declares second-quarter 2025 dividend",
      "source": "Yahoo",
      "datetime": 1746463620,
      "summary": "The board of directors of Eli Lilly and Company (NYSE:LLY) has declared a dividend for the second quarter of 2025 of $1.50 per share on outstanding common stock.",
      "url": "https://finnhub.io/api/news?id=4f66e300ef8e10406d667dfa6976193880db7325f64bf658461de28816ae2d71"
    },
    {
      "headline": "Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know",
      "source": "Yahoo",
      "datetime": 1746450014,
      "summary": "Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",
      "url": "https://finnhub.io/api/news?id=e563402c1256ed439787f01677e4f7bf1c37951ae477d6cada6bd7611f027698"
    },
    {
      "headline": "Fidelity Growth Company Fund Q1 2025 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1746437400,
      "summary": "For Q1 2025, the Fidelity Growth Company Fund returned -12.59%, lagging the -10.00% result of the benchmark. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=f684ff1054f87e3deae52c2226857f089032cff769834e5285d7983063d27b2e"
    },
    {
      "headline": "With compounders out of the way, Lilly and Novo go after each other",
      "source": "Yahoo",
      "datetime": 1746428728,
      "summary": "The two obesity leaders are pulling on all levers to stay on top of the market.",
      "url": "https://finnhub.io/api/news?id=dc646116c71dbc5a4e2c40875bbe6b6dd7e0ec73958163553e449ce277d437fd"
    },
    {
      "headline": "Eli Lilly First Quarter 2025 Earnings: EPS Misses Expectations",
      "source": "Yahoo",
      "datetime": 1746367848,
      "summary": "Eli Lilly ( NYSE:LLY ) First Quarter 2025 Results Key Financial Results Revenue: US$12.7b (up 45% from 1Q 2024). Net...",
      "url": "https://finnhub.io/api/news?id=5a866441a36e35b0fc9ddbed1e5074b07871cd02be80bcd78caa4f9e661cd78d"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-05-05",
      "description": "xslF345X05/wk-form4_1746476222.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000134/xslF345X05/wk-form4_1746476222.xml"
    },
    {
      "form": "10-Q",
      "date": "2025-05-01",
      "description": "lly-20250331.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000132/lly-20250331.htm"
    },
    {
      "form": "8-K",
      "date": "2025-05-01",
      "description": "lly-20250501.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000129/lly-20250501.htm"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745353361.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000124/xslF345X05/wk-form4_1745353361.xml"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745353273.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000122/xslF345X05/wk-form4_1745353273.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}